One of the problems that has long plagued the supplement industry has been the lack of transparency and associated trust issues that come with it. The unregulated nature of the industry has, at times, attracted bad actors, leading to a number of high-profile cases where extraordinary claims were made about products that later turned out to not be backed up by facts.
But now there is a new player on the scene. Elysium Health was founded in 2014 by Dr. Leonard Guarente, one of the top aging researchers in the United States and a professor at MIT. Dr. Guarente saw an opening for a new kind of health company that could help people stay healthier, longer. He brought several world-class scientists on board of Elysium Health to do so.
Elysium Health is in the process of researching several new products, but for the moment only Basis is available for purchase. Basis is aimed at supporting cellular health by boosting levels of a critical molecule called NAD+ that the body uses in several essential biological processes.
Short for nicotinamide adenine dinucleotide, NAD+ is a crucial component energy creation, DNA maintenance, and regulation of circadian rhythms. NAD+ levels naturally decline as we age, so Basis works to maintain higher levels of the coenzyme in our cells.
Elysium Health put Basis through a clinical trial in order to make sure that their claims could be backed up by the effects of the supplement. Using 120 adults as part of an eight-week study, the trial proved that Basis increases levels of NAD+ in humans by an average of 40 percent.
Basis is available for purchase on Elysium Health’s website. A subscription to the supplement is available for $50 a month. For those pre-ordering a six-month or one-year supply of Basis, the company offers a discounted rate.